Johnson & Johnson Company Profile (NYSE:JNJ)

Analyst Ratings

Consensus Ratings for Johnson & Johnson (NYSE:JNJ) (?)
Ratings Breakdown: 1 Sell Rating(s), 12 Hold Rating(s), 10 Buy Rating(s)
Consensus Rating:Hold (Score: 2.39)
Consensus Price Target: $117.91 (5.26% downside)

Analysts' Ratings History for Johnson & Johnson (NYSE:JNJ)
Show:
DateFirmActionRatingPrice TargetActions
7/21/2016Deutsche Bank AGReiterated RatingHold$125.00 -> $142.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/20/2016RBC Capital MarketsReiterated RatingOutperform$125.00 -> $133.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/20/2016Leerink SwannReiterated RatingOutperform$125.00 -> $140.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/20/2016BMO Capital MarketsReiterated RatingOutperform$132.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/20/2016Royal Bank Of CanadaBoost Price TargetOutperform$125.00 -> $133.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2016Jefferies GroupBoost Price TargetHold$109.00 -> $113.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/11/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/10/2016Barclays PLCReiterated RatingOverweight$120.00 -> $125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016Goldman Sachs Group Inc.Set Price TargetNeutral$121.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2016BTIG ResearchReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/20/2016Raymond James Financial Inc.Reiterated RatingOutperform$120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/20/2016Standpoint ResearchInitiated CoverageSell$94.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016Bank of America Corp.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016Morgan StanleyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016Credit Suisse Group AGReiterated RatingHold$112.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2016Piper Jaffray Cos.Boost Price TargetNeutral$105.00 -> $106.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2016ArgusBoost Price TargetBuy$116.00 -> $130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2016JPMorgan Chase & Co.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2016Societe GeneraleInitiated CoverageHold$113.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016Independent Research GmbHSet Price TargetNeutral$108.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2015Atlantic SecuritiesInitiated CoverageNeutral$95.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/15/2015S&P Equity ResearchReiterated RatingBuy$120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2015Cowen and CompanyReiterated RatingOutperform$114.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2014GuggenheimInitiated CoverageNeutral$115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2014Sanford C. BernsteinDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Johnson & Johnson (NYSE:JNJ)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/11/2016        
7/19/2016Q216$1.68$1.74$17.98 billion$18.50 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/19/2016Q116$1.65$1.68$17.50 billion$17.50 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/26/2016Q415$1.42$1.44$17.88 billion$17.80 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/13/2015Q315$1.45$1.49$17.47 billion$17.10 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/14/2015Q215$1.69$1.71$17.76 billion$17.80 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/14/2015Q115$1.54$1.56$17.40 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/20/2015Q414$1.26$1.27$18.59 billion$18.30 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/14/2014Q314$1.43$1.50$18.41 billion$18.50 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/15/2014Q214$1.54$1.66$18.86 billion$19.50 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/15/2014Q114$1.48$1.54$18.00 billion$18.10 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/21/2014Q413$1.20$1.24$17.95 billion$18.40 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/15/2013Q313$1.32$1.36$17.46 billion$17.60 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/16/2013Q2 2013$1.39$1.48$17.71 billion$17.90 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/16/2013Q1 2013$1.41$1.44$17.46 billion$17.50 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/22/2013Q4 2012$1.17$1.19$17.67 billion$17.60 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/16/2012$1.21$1.25ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/17/2012$1.29$1.30ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/17/2012$1.34$1.37ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/24/2012$1.09$1.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/18/2011$1.21$1.24ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/19/2011$1.24$1.28ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/19/2011$1.26$1.35ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/25/2011$1.03$1.03ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Johnson & Johnson (NYSE:JNJ)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$1.60$1.67$1.64
Q2 20163$1.64$1.68$1.66
Q3 20161$1.63$1.63$1.63
Q4 20161$1.59$1.59$1.59
Q1 20172$1.69$1.73$1.71
Q2 20171$1.82$1.82$1.82
Q3 20171$1.82$1.82$1.82
Q4 20171$1.79$1.79$1.79
Q1 20181$1.91$1.91$1.91
Q2 20181$2.00$2.00$2.00
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Johnson & Johnson (NYSE:JNJ)
Annual Dividend:$3.20
Dividend Yield:2.57%
Payout Ratio:60.15% (Based on Trailing 12 Months of Earnings)
47.83% (Based on Current Year Consensus EPS Estimate)
45.01% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:7.10% (3 Year Average)

Dividend History for Johnson & Johnson (NYSE:JNJ)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
7/20/2016quarterly$0.298/5/20168/19/2016Tweet This Announcement  Share This Announcement on StockTwits
7/18/2016quarterly$0.808/19/20168/23/20169/6/2016Tweet This Announcement  Share This Announcement on StockTwits
4/28/2016quarterly$0.805/20/20165/24/20166/7/2016Tweet This Announcement  Share This Announcement on StockTwits
1/4/2016quarterly$0.752/19/20162/23/20163/8/2016Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015quarterly$0.7511/20/201511/24/201512/8/2015Tweet This Announcement  Share This Announcement on StockTwits
7/20/2015quarterly$0.758/21/20158/25/20159/8/2015Tweet This Announcement  Share This Announcement on StockTwits
4/23/2015quarterly$0.752.97%5/21/20155/26/20156/9/2015Tweet This Announcement  Share This Announcement on StockTwits
1/5/2015quarterly$0.702.71%2/20/20152/24/20153/10/2015Tweet This Announcement  Share This Announcement on StockTwits
10/16/2014quarterly$0.702.89%11/21/201411/25/201412/9/2014Tweet This Announcement  Share This Announcement on StockTwits
7/21/2014quarterly$0.702.73%8/22/20148/26/20149/9/2014Tweet This Announcement  Share This Announcement on StockTwits
4/24/2014quarterly$0.702.81%5/22/20145/27/20146/10/2014Tweet This Announcement  Share This Announcement on StockTwits
1/2/2014quarterly$0.662.87%2/21/20142/25/20143/11/2014Tweet This Announcement  Share This Announcement on StockTwits
10/17/2013quarterly$0.662.88%11/22/201311/26/201312/10/2013Tweet This Announcement  Share This Announcement on StockTwits
7/15/2013quarterly$0.662.92%8/23/20138/27/20139/10/2013Tweet This Announcement  Share This Announcement on StockTwits
4/25/2013quarterly$0.663.1%5/23/20135/28/20136/11/2013Tweet This Announcement  Share This Announcement on StockTwits
1/2/2013quarterly$0.613.45%2/22/20132/26/20133/12/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Johnson & Johnson (NYSE:JNJ)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/26/2016Dominic J CarusoVPSell41,146$125.01$5,143,661.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2016Ronald A KapustaCAOSell2,935$125.01$366,904.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2016Gary J PrudenVPSell9,735$116.03$1,129,552.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2016Ronald A KapustaCAOSell3,000$115.79$347,370.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2016Ronald A KapustaCAOSell3,957$114.77$454,144.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2016Paulus StoffelsinsiderSell125,000$102.43$12,803,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016Peter FasoloVPSell151,385$104.12$15,762,206.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2015Ronald A. KapustaCAOSell6,239$99.68$621,903.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2015Charles PrinceDirectorBuy2,500$99.22$248,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2015Paulus StoffelsInsiderSell187,250$100.73$18,861,692.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014James CullenDirectorSell2,446$104.12$254,677.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2014Stephen CosgroveInsiderSell22,000$100.05$2,201,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2014Peter FasoloVPSell6,824$93.15$635,655.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Stephen CosgroveInsiderSell17,200$91.39$1,571,908.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013Michael UllmannVPSell16,140$93.68$1,511,995.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2013Paulus StoffelsInsiderSell45,440$92.40$4,198,656.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/18/2013Dominic J CarusoCFOSell30,000$90.31$2,709,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2012James CullenDirectorSell13,900$69.70$968,830.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Johnson & Johnson (NYSE:JNJ)
DateHeadline
07/28/16 04:33 PMShould Johnson & Johnson Investors Be Worried About Ovarian Cancer Link? -
07/28/16 09:34 AMBetter Buy: Johnson & Johnson vs. Pfizer -
07/28/16 07:49 AMJohnson & Johnson (NYSE:JNJ), Genmab Get New FDA ... - Market Exclusive
07/28/16 07:49 AMJohnson & Johnson Delivers Strong Results - Seeking Alpha
07/28/16 07:49 AMJohnson & Johnson (NYSE:JNJ) nearing 52-week high, short ... - Street Report
07/28/16 07:49 AMPrice Target Spotlight: Johnson & Johnson (NYSE:JNJ) - News Oracle
07/28/16 02:58 AMWeak China sales drag down Smith & Nephew profits -
07/27/16 05:02 PMJohnson & Johnson Is Getting Rather Expensive
07/27/16 05:02 PMJohnson & Johnson (NYSE:JNJ), Genmab Get New FDA Breakthrough Designation
07/27/16 05:02 PMJohnson & Johnson Delivers Strong Results
07/27/16 07:36 AMStocks inside Analysts Spotlight: Johnson & Johnson (NYSE:JNJ) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Street Updates
07/27/16 07:36 AMJohnson & Johnson (JNJ) Closes 0.21% Up on the Day for July 26 - Equities.com
07/27/16 07:36 AMLynch Associatesin Lowers stake in Johnson & Johnson (JNJ) - Trade Calls
07/27/16 07:16 AMKey Takeaways From Johnson & Johnson's Q2 Earnings Report -
07/26/16 04:59 PMJohnson & Johnson: 1 Dividend Stock to Own Forever
07/26/16 04:59 PMJohnson & Johnson: Patience Finally Beginning To Pay Off
07/26/16 07:47 AMStocks within Analysts Screening: Johnson & Johnson (NYSE:JNJ ... - Street Updates
07/26/16 07:47 AMJohnson And Johnson: No Time To Wait - Seeking Alpha
07/26/16 07:47 AMRecommendation Trends: Johnson & Johnson (NYSE:JNJ) - News Oracle
07/26/16 07:47 AMJohnson & Johnson (JNJ) Closes 0.11% Down on the Day for July 25 - Equities.com
07/25/16 04:55 PMJNJ’s Q2 Results Reaffirm Our Stance For Pharmaceutical Growth
07/25/16 04:55 PMDeutsche Bank announced (NYSE:JNJ) Johnson & Johnson, stepping up its stock price target to $142 earlier today
07/25/16 04:55 PMOne Put, One Call Option To Know About for Johnson & Johnson
07/25/16 04:55 PMJohnson & Johnson: Great Quality, But Stock Has No Margin Of Safety
07/25/16 03:05 PMThe Death Of Brand Loyalty: Cultural Shifts Mean It's Gone Forever -
07/25/16 11:50 AMIs Johnson & Johnson ready for pullback? -
07/25/16 09:19 AMHC Stocks in the Rumor: Johnson & Johnson (NYSE:JNJ) Humana Inc (NYSE:HUM) - share market updates (press release)
07/25/16 09:19 AMJohnson & Johnson (JNJ) Shares are Up 1.65% - Trade Calls
07/25/16 08:30 AMThe Zacks Analyst Blog Highlights: Bank of America, Chevron, Exxon Mobil, Johnson & Johnson and McDonald -
07/24/16 04:24 PMDeutsche Bank announced (NYSE:JNJ) Johnson & Johnson, stepping up its stock price target to $142 earlier today - Breaking Finance News
07/24/16 04:24 PMJohnson & Johnson (JNJ) Closes 0.1% Down on the Day for July 22 - Equities.com
07/24/16 10:57 AM3 Important Takeaways From Johnson & Johnson's Second-Quarter Earnings - Here's what investors ought to know about Johnson & Johnson's financial performance last quarter.
07/24/16 09:06 AMJohnson & Johnson: A Dividend King With 54 Years Of Dividend Increases (Part 12 Of 18)
07/23/16 04:29 PMJohnson and Johnson Reports 4% Sales Growth for the Second Quarter
07/23/16 08:46 AMAnalyst Overview: Johnson & Johnson (NYSE:JNJ) - News Oracle
07/22/16 04:44 PMAcclarent launches Relieva Scout multi-sinus dilator
07/22/16 04:44 PMJohnson & Johnson: 3 Reasons To Be Optimistic From The Q2 Results
07/22/16 04:22 PMJohnson & Johnson Reports 4% Sales Growth for the Second Quarter -
07/22/16 03:52 PMBetter Buy: Intuitive Surgical, Inc. vs. Johnson & Johnson - Unlike last time, we now have a definitive winner.
07/22/16 03:39 PM[$$] Johnson & Johnson's Acclarent Unit in $18 Million U.S. Settlement -
07/22/16 07:45 AMJohnson & Johnson: The Frenzy Continues
07/22/16 05:21 AM11 Big Brands Stats That Will Blow You Away -
07/21/16 04:56 PMJohnson & Johnson: The Frenzy Continues - Seeking Alpha
07/21/16 04:56 PMWoodley Farra Manion Portfolio Management Inc Lowers stake in Johnson & Johnson (JNJ) - TheFounders Daily
07/21/16 04:56 PMJohnson & Johnson (JNJ) Closes 0.01% Up on the Day for July 21 - Equities.com
07/21/16 04:56 PMJohnson & Johnson (JNJ) Gets Price Target Hike at Deutsche Bank - TheStreet.com
07/21/16 04:25 PMWhat Will Happen to the Stock Market When Interest Rates Rise? Part 1 -
07/21/16 03:52 PMTwo Former Johnson & Johnson Execs Just Got Convicted for Improper Marketing -
07/21/16 02:50 PMJohnson & Johnson (JNJ) Gets Price Target Hike at Deutsche Bank -
07/21/16 01:01 PMResearch Reports on Facebook (FB), Tesla (TSLA) & Others -

Social

About Johnson & Johnson

Johnson & Johnson logoJohnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company's segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on over five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: JNJ
  • CUSIP: 47816010
Key Metrics:
  • Previous Close: $124.46
  • 50 Day Moving Average: $120.43
  • 200 Day Moving Average: $110.97
  • P/E Ratio: 23.19
  • P/E Growth: 2.86
  • Market Cap: $342.35B
  • Beta: 0.57
  • Current Year EPS Consensus Estimate: $6.69 EPS
  • Next Year EPS Consensus Estimate: $7.11 EPS
Additional Links:
Johnson & Johnson (NYSE:JNJ) Chart for Thursday, July, 28, 2016